COINTURK FINANCECOINTURK FINANCECOINTURK FINANCE
  • Investing
  • Technology News
  • Business
  • Fintech
  • Startup
  • About Us
  • Contact
Search
Health
  • About Us
  • Contact
Entertainment
  • Investing
  • Business
  • Fintech
  • Startup
© 2024 BLOCKCHAIN IT. >> COINTURK FINANCE
Powered by LK SOFTWARE
Reading: myTomorrows Partners with Pancreatic Cancer Europe
Share
Font ResizerAa
COINTURK FINANCECOINTURK FINANCE
Font ResizerAa
Search
  • Investing
  • Technology News
  • Business
  • Fintech
  • Startup
  • About Us
  • Contact
Follow US
© 2025 BLOCKCHAIN Information Technologies. >> COINTURK FINANCE
Powered by LK SOFTWARE
Track all markets on TradingView
COINTURK FINANCE > Startup > myTomorrows Partners with Pancreatic Cancer Europe
Startup

myTomorrows Partners with Pancreatic Cancer Europe

Overview

  • myTomorrows partners with Pancreatic Cancer Europe.

  • Partnership aims to enhance access to clinical trials.

  • New tool simplifies finding relevant treatment options.

COINTURK FINANCE
COINTURK FINANCE 10 months ago
SHARE

myTomorrows, a global health technology firm, has announced its partnership with Pancreatic Cancer Europe to streamline access to clinical trial information. This collaboration aims to help patients, caregivers, and healthcare professionals make informed decisions regarding pre-approval treatments. By utilizing myTomorrows’ extensive database, Pancreatic Cancer Europe looks to provide up-to-date and accessible treatment options to those battling pancreatic cancer.

Contents
Enhanced Access to Clinical TrialsStatements from Leaders

Pancreatic cancer remains a daunting health challenge, being the fourth leading cause of cancer-related deaths globally. The disease is characterized by late diagnosis, treatment resistance, and limited treatment options, leading to a grim life expectancy of just 6-12 months post-diagnosis and a five-year survival rate of only 10%. The critical need for accurate and comprehensive information on treatment options, particularly clinical trials, has been emphasized by various health experts.

Enhanced Access to Clinical Trials

The new partnership will introduce a clinical trial search tool on the Pancreatic Cancer Europe website, significantly easing the process of finding relevant treatment options globally. myTomorrows’ expert patient navigators will assist in demystifying the complexities of clinical trials, providing continuous support to patients and families. This tool aims to accelerate and simplify the search for suitable clinical trials for pancreatic cancer patients.

Pancreatic Cancer Europe hopes this collaboration will enable patients to take a proactive and informed approach to their treatment. This move aligns with their ongoing efforts to raise awareness and promote advancements in pancreatic cancer treatments. The partnership also aims to enhance communication between patients, caregivers, and healthcare professionals, facilitating better decision-making.

Statements from Leaders

“We are very excited to be partnering with Pancreatic Cancer Europe, an organisation that works tirelessly to raise awareness of pancreatic cancer, promote advancements in treatments, and empower European member organisations to better address the relevant issues regarding the disease,” said Dr. Michel van Harten, CEO of myTomorrows. “Collaborating with leading patient advocacy groups like PCE helps us extend our reach to more patients in need and empower them to navigate their treatment journeys with more confidence and knowledge, while enabling pharmaceutical companies to expand access throughout the drug development cycle.”

“This new partnership is an important step in the persistent fight against pancreatic cancer,” said Prof. Alfredo Carrato, Chair of Pancreatic Cancer Europe. “The innovative myTomorrows platform will support patients suffering from pancreatic cancer, their caregivers and their treating physicians by significantly easing the process of accessing and navigating clinical trials, another opportunity for them, enabling a more informed and proactive approach to treatment of this devastating disease.”

The new collaboration between myTomorrows and Pancreatic Cancer Europe represents a significant step forward in the fight against pancreatic cancer. By making clinical trial information more accessible and understandable, this partnership could potentially improve survival rates and the quality of life for patients. Healthcare professionals will also benefit from having a more streamlined process for identifying suitable clinical trials, ultimately leading to better patient outcomes.

You can follow our news on Telegram and Twitter (X)
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.

You Might Also Like

Alexandr Wang Joins Meta to Propel A.I. Ambitions After Scale AI Stake Sale

Sunrise Robotics Secures $8.5 Million to Bolster European Manufacturing

Startup Converts Air into Gasoline for Carbon-Neutral Driving

Veriam Combines Access Control and Subscription Management for SaaS

Mattel Embraces AI for Next-Gen Toys with OpenAI Partnership

Share This Article
Facebook Twitter Copy Link Print
Previous Article MMI Secures €7.7M for Electric Bus Development
Next Article Octopus Energy Expands Its EV Charging Platform
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

US Companies Initiate Job Cuts Due to Tariff-Driven Uncertainty
COINTURK FINANCE COINTURK FINANCE 3 hours ago
Private Equity Eyes Metro Bank for Potential Takeover
COINTURK FINANCE COINTURK FINANCE 5 hours ago
Refiners Outperform S&P 500, Offering Consistent Dividends and Returns
COINTURK FINANCE COINTURK FINANCE 5 hours ago
Early Retirement Leads to Unexpected Life Changes for Wealthy Couple
COINTURK FINANCE COINTURK FINANCE 15 hours ago
Investors Choose Long-Term Strategies with Promising Stocks
COINTURK FINANCE COINTURK FINANCE 17 hours ago
//

COINTURK was launched in March 2014 by a group of tech enthusiasts focused on the internet and new technologies.

CATEGORIES

  • Investing
  • Business
  • Fintech
  • Startup

OUR PARTNERS

  • COINTURK NEWS
  • BH NEWS
  • NEWSLINKER

OUR COMPANY

  • About Us
  • Contact
COINTURK FINANCECOINTURK FINANCE
Follow US
© 2025 BLOCKCHAIN Information Technologies. >> COINTURK FINANCE
Powered by LK SOFTWARE
Welcome Back!

Sign in to your account

Lost your password?